Avid Bioservices Inc (CDMO)

[Frustrated]

Lets see so far in just the last year and a half we have had the disappointment of the Duke Paper and Haynes, the R/S which we still have not recovered from, no significant license deals athough we have been in talks for years, no significant mgmt purchases, no Bavi updates for ASCO and now the Cotara dud news. Can we really expect mgmt to pull off something positive with the FDA meeting? Why do we just say it is in the 4th quarter, is it scheduled yet? With mgmt timelines we can probably guess it will actually take place in the 2nd quarter next year?

Where is the signal seeking data or will that disappear like Dios, China, Medipharm?

It is amazing as I was reading old posts around the RS time with everybody talking about how mgmt would have something up their sleeve like the Duke paper or a Cotara license and that was back in September 2009! How long does this team get a free pass?